Last reviewed · How we verify

NCT06656520

Impact of Telehealth Care

Withdrawn Last updated 24 October 2024
What this trial tests

trial in Telehealth Services. Withdrawn.

Timeline
2 October 2023
Primary endpoint
2 October 2026
31 October 2026

Quick facts

Lead sponsorPei-Hung Liao
StatusWithdrawn
Study typeOBSERVATIONAL
Start date2 October 2023
Primary completion2 October 2026
Estimated completion31 October 2026

Conditions studied

Sponsor

Pei-Hung Liao

Who can join

Eligibility, any sex, with Telehealth Services or Telehealth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Heart failure is associated with high incidence and mortality rates, limited physical activity, decreased quality of life, and increased healthcare expenses. Implementing a Telehealth Care (TC) HF program could address these challenges while improving patient outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Pei-Hung Liao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06656520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing